![Vanguard Eur Eurozone Government Bond Ucits Etf](/common/images/company/BIT_VETY.png)
GSK PLC on Monday said its Arexvy offering received a "positive opinion" from the European Medicines Agency's Committ ...
GSK PLC 29 July 2024 Issued: 29 July 2024, London UK Statement: Zantac (ranitidine) litigation - Kimbrow case GSK plc (LSE/NYSE: GSK) has reached a confidential settlement with...
GSK PLC 29 July 2024 Issued: 29 July 2024, London UK Arexvy, GSK's Respiratory Syncytial Virus (RSV) vaccine, receives positive European Medicines Agency CHMP opinion for adults aged 50-59...
GSK PLC on Tuesday reported "positive" data for testing on three different treatments by ViiV Healthcare, its majorit ...
GSK PLC 19 July 2024 Issued: 19 July 2024, London UK Blenrep (belantamab mafodotin) combinations in multiple myeloma application accepted for review by the European Medicines Agency ●...
GSK PLC on Friday said its treatment for relapsed or refractory multiple myeloma has been accepted for review by a Eu ...
GSK PLC 18 July 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Emma Walmsley b) Position/status Chief Executive...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.